Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors K¿v?1.5 which has been linked to the ultra-rapidly activating delayed rectifier K?+¿ current I¿Kur?), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
新型杂环二氢
嘧啶化合物可作为
钾通道功能
抑制剂使用(特别是Kv1亚家族电压门控K+通道的
抑制剂,特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5
抑制剂),使用这种化合物预防和治疗心律失常和IKur相关疾病的方法,以及含有这种化合物的制药组合物。